Psoriasis is a chronic skin condition that requires long-term treatment and monitoring. Although, the Psoriasis Area and Severity Index (PASI) is utilized as a standard measurement to assess psoriasis severity in clinical trials, it has many drawbacks such as (1) patient burden for in-person clinic visits for assessment of psoriasis, (2) time required for investigator scoring and (3) variability of inter- and intra-rater scoring. To address these drawbacks, we propose a novel and interpretable deep learning architecture called PSO-Net, which maps digital images from different anatomical regions to derive attention-based scores. Regional scores are further combined to estimate an absolute PASI score. Moreover, we devise a novel regression activation map for interpretability through ranking attention scores. Using this approach, we achieved inter-class correlation scores of 82.2% [95% CI: 77- 87%] and 87.8% [95% CI: 84-91%] with two different clinician raters, respectively.
Psoriasis is a long-term inflammatory skin disease that remains difficult to treat. In this study, we developed a new topical treatment by combining metal oxide nanoparticles: cerium oxide (CeO2), zinc oxide (ZnO), and silver (Ag), with natural plant extracts in a gel made from fish collagen and agar. The nanoparticles were characterized using UV-Vis spectroscopy, dynamic light scattering (DLS), Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM), showing good stability and a uniform particle size distribution (ZnO averaged 66 nm). To enhance therapeutic potential, the gel was enriched with plant-derived antioxidants from bitter melon, ginger, and neem. This formulation was tested on an animal model of psoriasis. The treated group exhibited faster wound healing and reduced inflammation compared to both placebo and untreated groups, with statistically significant results (p < 0.01 to p < 0.001) observed from Day 3, becoming more pronounced by Day 14. These results indicate that the combination of nanoparticles with plant-based components in a topical gel may provide a promising new approach to psoriasis treatment. Further studies are recommen
In this paper a comparative study of the performance of three Convolutional Neural Network models, ResNet50, Inception v3 and VGG19 for classification of skin images with lesions affected by psoriasis is presented. The images used for training and validation of the models were obtained from specialized platforms. Some techniques were used to adjust the evaluation metrics of the neural networks. The results found suggest the model Inception v3 as a valuable tool for supporting the diagnosis of psoriasis. This is due to its satisfactory performance with respect to accuracy and F1-Score (97.5% ${\pm}$ 0.2).
Psoriasis (PsO) severity scoring is important for clinical trials but is hindered by inter-rater variability and the burden of in person clinical evaluation. Remote imaging using patient captured mobile photos offers scalability but introduces challenges, such as variation in lighting, background, and device quality that are often imperceptible to humans but can impact model performance. These factors, along with inconsistencies in dermatologist annotations, reduce the reliability of automated severity scoring. We propose a framework to automatically flag problematic training images that introduce spurious correlations which degrade model generalization, using a gradient based interpretability approach. By tracing the gradients of misclassified validation images, we detect training samples where model errors align with inconsistently rated examples or are affected by subtle, nonclinical artifacts. We apply this method to a ConvNeXT based weakly supervised model designed to classify PsO severity from phone images. Removing 8.2% of flagged images improves model AUC-ROC by 5% (85% to 90%) on a held out test set. Commonly, multiple annotators and an adjudication process ensure annotati
Skin diseases can arise from infections, allergies, genetic factors, autoimmune disorders, hormonal imbalances, or environmental triggers such as sun damage and pollution. Some skin diseases, such as Actinic Keratosis and Psoriasis, can be fatal if not treated in time. Early identification is crucial, but the diagnostic methods for these conditions are often expensive and not widely accessible. In this study, we propose a novel and efficient method for diagnosing skin diseases using deep learning techniques. This approach employs a modified VGG16 Convolutional Neural Network (CNN) model. The model includes several convolutional layers and utilizes ImageNet weights with modified top layers. The top layer is updated with fully connected layers and a final softmax activation layer to classify skin diseases. The dataset used, titled "Skin Disease Dataset," is publicly available. While the VGG16 architecture does not include data augmentation by default, preprocessing techniques such as rotation, shifting, and zooming were applied to augment the data prior to model training. The proposed methodology achieved 90.67% accuracy using the modified VGG16 model, demonstrating its reliability i
Background. Real-world data show that approximately 50% of psoriasis patients treated with a biologic agent will discontinue the drug because of loss of efficacy. History of previous therapy with another biologic, female sex and obesity were identified as predictors of drug discontinuations, but their individual predictive value is low. Objectives. To determine whether machine learning algorithms can produce models that can accurately predict outcomes of biologic therapy in psoriasis on individual patient level. Results. All tested machine learning algorithms could accurately predict the risk of drug discontinuation and its cause (e.g. lack of efficacy vs adverse event). The learned generalized linear model achieved diagnostic accuracy of 82%, requiring under 2 seconds per patient using the psoriasis patients dataset. Input optimization analysis established a profile of a patient who has best chances of long-term treatment success: biologic-naive patient under 49 years, early-onset plaque psoriasis without psoriatic arthritis, weight < 100 kg, and moderate-to-severe psoriasis activity (DLQI $\geq$ 16; PASI $\geq$ 10). Moreover, a different generalized linear model is used to pre
We present a computational model to study the spatiotemporal dynamics of the epidermis homeostasis under normal and pathological conditions. The model consists of a population kinetics model of the central transition pathway of keratinocyte proliferation, differentiation and loss and an agent-based model that propagates cell movements and generates the stratified epidermis. The model recapitulates observed homeostatic cell density distribution, the epidermal turnover time and the multilayered tissue structure. We extend the model to study the onset, recurrence and phototherapy-induced remission of psoriasis. The model considers the psoriasis as a parallel homeostasis of normal and psoriatic keratinocytes originated from a shared stem-cell niche environment and predicts two homeostatic modes of the psoriasis: a disease mode and a quiescent mode. Interconversion between the two modes can be controlled by interactions between psoriatic stem cells and the immune system and by the normal and psoriatic stem cells competing for growth niches. The prediction of a quiescent state potentially explains the efficacy of the multi-episode UVB irradiation therapy and recurrence of psoriasis plaqu
Background: Psoriasis is a multifactorial chronic inflammatory disorder of the skin with significant morbidity, characterized by hyper proliferation of the epidermis. Even though psoriasis etiology is not fully understood, it is believed to be multifactorial with numerous key components. Methods: In order to cast light on the complex molecular interactions in psoriasis vulgaris at both protein-protein interactions and transcriptomics levels, we analyzed a set of microarray gene expression analysis consisting of 170 paired lesional and non-lesional samples. Afterwards, a network analysis was conducted on protein-protein interaction network of differentially expressed genes based on micro- and macro-level network metrics at a systemic level standpoint. Results: We found 17 top communicative genes, all of which experimentally proven to be pivotal in psoriasis were identified in two modules, namely, cell cycle and immune system. Intra- and inter-gene interaction subnetworks from the top communicative genes might provide further insight into the corresponding characteristic mechanisms. Conclusions: Potential gene combinations for therapeutic/diagnostics purposes were identified. Moreove
Disease psoriasis occurs as chronic inflammation of skin and appears as scaly red lesions on skin surface. Advent of several immunosuppressive drugs established that the disease stems from immuno-pathogenic disorder in human blood. Cell biological as well as clinical research on the disease reveals that the helper T-cells and other Leucocytes, responsible for human immunity, may lead to psoriasis pathogenesis if produced in plenty at locations close to the dermal region. Research findings also showed that a complex, self-sustaining (cytokine and related) proteins network play important role in disease maturation by actually leading to a huge proliferation of epidermal keratinocytes. Disease pathogenesis is identified with such hyperproliferation leading to flaking of skin surface (psoriatic plaques). An excessive generation of nitric oxide by proliferated keratinocytes, through a complex chain of bio-chemical events, is causal to the scaliness of psoriatic plaques. Considering these immunopathogenic mechanisms, we propose and analyse a mathematical time differential model for the disease psoriasis. Outcomes of analysis are consistent with existing cell biological and clinical findi
Psoriasis is a complex disease with many variations in genotype and phenotype. General advancements in medicine has further complicated both assessments and treatment for both physicians and dermatologist alike. Even with all of our technological progress we still primarily use the assessment tool Psoriasis Area and Severity Index (PASI) for severity assessments which was developed in the 1970s. In this study we evaluate a method involving digital images, a comparison web application and similarity clustering, developed to improve the assessment tool in terms of intra- and inter-observer variation. Images of patients was collected from a mobile device. Images were captured of the same lesion area taken approximately 1 week apart. Five dermatologists evaluated the severity of psoriasis by modified-PASI, absolute scoring and a relative pairwise PASI scoring using similarity-clustering and conducted using a web-program displaying two images at a time. mPASI scoring of single photos by the same or different dermatologist showed mPASI ratings of 50% to 80%, respectively. Repeated mPASI comparison using similarity clustering showed consistent mPASI ratings > 95%. Pearson correlation b
Accurate estimation of the body surface area (BSA) involved by a rash, such as psoriasis, is critical for assessing rash severity, selecting an initial treatment regimen, and following clinical treatment response. Attempts at segmentation of inflammatory skin disease such as psoriasis perform markedly worse on darker skin tones, potentially impeding equitable care. We assembled a psoriasis dataset sourced from six public atlases, annotated for Fitzpatrick skin type, and added detailed segmentation masks for every image. Reference models based on U-Net, ResU-Net, and SETR-small are trained without tone information. On the tuning split we sweep decision thresholds and select (i) global optima and (ii) per Fitzpatrick skin tone optima for Dice and binary IoU. Adapting Fitzpatrick specific thresholds lifted segmentation performance for the darkest subgroup (Fitz VI) by up to +31 % bIoU and +24 % Dice on UNet, with consistent, though smaller, gains in the same direction for ResU-Net (+25 % bIoU, +18 % Dice) and SETR-small (+17 % bIoU, +11 % Dice). Because Fitzpatrick skin tone classifiers trained on Fitzpatrick-17k now exceed 95 % accuracy, the cost of skin tone labeling required for th
Case-control designs are fundamental in epidemiology for the efficient study of rare outcomes. Although instrumental variable (IV) methods have been extended to this setting to address unmeasured confounding, they typically rely on the exclusion restriction assumption, which may be violated when the IV candidates directly affect the outcome through pathways independent of the exposure. In this paper, we propose a novel instrumented difference-in-differences (iDiD) approach tailored to case-control designs. Grounded in structural mean modeling, the proposed method accommodates IV candidates that have time-invariant direct effect on the outcome. When retrospective case-control datasets are collected, the candidate can still be used as a valid instrument on the trend scale when selection bias induced by retrospective sampling is efficiently taken into account. We assess finite-sample performance of this method through extensive simulations, then apply it to evaluate the risk of serious infection of biologic treatments for psoriasis, using French national claim database.
Multilevel network meta-regression (ML-NMR) enables population-adjusted indirect treatment comparisons by combining individual patient data (IPD) with aggregate data. When individual-level covariates are unavailable, ML-NMR marginalizes over the covariate distribution, but this strategy cannot exploit subgroup-level summary results that are often available and potentially highly informative. We propose using Bayesian Synthetic Likelihood (BSL) to leverage this ancillary summary information and present an implementation strategy for Hamiltonian Monte Carlo (HMC), a gradient-based Markov chain Monte Carlo (MCMC) algorithm. At each MCMC iteration, the BSL method imputes missing covariates by sampling from the model-implied conditional distribution, computes synthetic subgroup summaries from the imputed data, and matches these synthetic summaries to observed summaries via a multivariate normal synthetic likelihood. Fitting this model with HMC presents multiple challenges: first, gradients cannot be computed exactly but must be estimated stochastically; and second, the model's likelihood may be non-differentiable at certain points, a pathology that can deeply frustrate the performance o
This paper presents a comparison of the performance of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) in the task of multi-classifying images containing lesions of psoriasis and diseases similar to it. Models pre-trained on ImageNet were adapted to a specific data set. Both achieved high predictive metrics, but the ViTs stood out for their superior performance with smaller models. Dual Attention Vision Transformer-Base (DaViT-B) obtained the best results, with an f1-score of 96.4%, and is recommended as the most efficient architecture for automated psoriasis detection. This article reinforces the potential of ViTs for medical image classification tasks.
Background Hybrid clinical trial design integrates randomized controlled trials (RCTs) with real-world data (RWD) to enhance efficiency through dynamic incorporation of external data. Existing methods like the Meta-Analytic Predictive Prior (MAP) inadequately control data heterogeneity, adjust baseline discrepancies, or optimize dynamic borrowing proportions, introducing bias and limiting applications in bridging trials and multi-regional clinical trials (MRCTs). Objective This study proposes a novel hybrid Bayesian framework (EQPS-rMAP) to address heterogeneity and bias in multi-source data integration, validated through simulations and retrospective case analyses of risankizumab's efficacy in moderate-to-severe plaque psoriasis. Design and Methods EQPS-rMAP eliminates baseline covariate discrepancies via propensity score stratification, constructs stratum-specific MAP priors to dynamically adjust external data weights, and introduces equivalence probability weights to quantify data conflict risks. Performance was evaluated across six simulated scenarios (heterogeneity differences, baseline shifts) and real-world case analyses, comparing it with traditional methods (MAP, PSMAP, EB
Learning about causal effects in target populations and their subsets may be facilitated by combining information from multiple sources. One major class of study designs that combine information involves appending an index study with data from an external comparator, which may facilitate head-to-head comparisons of treatments initially studied in different populations. We delineate external comparator analyses under two distinct, but related, identification strategies. The first strategy relies on exchangeability (transportability) of potential outcome means, which uses information only on the treatments that are to be compared. The second strategy relies on transportability in effect measure, requiring additional use of information on a third treatment common to the populations that have been combined. In a time-fixed setting with a point treatment and non-failure time outcome, we examine identification and estimation under a basic setup where information from an index trial is combined with a second, and external to the index trial, data source. We propose estimators for identifying observed data functionals, with a particular focus on semiparametric efficient augmented weighting
SkinGPT-4, a large vision-language model, leverages annotated skin disease images to augment clinical workflows in underserved communities. However, its training dataset predominantly represents lighter skin tones, limiting diagnostic accuracy for darker tones. Here, we evaluated performance biases in SkinGPT-4 across skin tones on common skin diseases, including eczema, allergic-contact dermatitis, and psoriasis using the open-sourced SCIN dataset. We leveraged the SkinGPT-4 backbone to develop finetuned models for custom skin disease classification tasks and explored bias mitigation strategies. Clinical evaluation by board-certified dermatologists on six relevant skin diseases from 300 SCIN cases assessed images for diagnostic accuracy, informativity, physician utility, and patient utility. Model fairness metrics, including demographic parity and equalized odds, were calculated across skin tones. SkinGPT-4 achieved an average demographic parity of 0.10 across Fitzpatrick types, with notable differences of 0.10-0.15 between lightest and darkest tones across evaluation metrics. Model hallucinations in artifacts and anatomy occurred at a rate of 17.8. Our customized models achieved
The amendments made to the Data 3 Act and impact of COVID-19 have fostered the growth of digital healthcare market and promoted the use of medical data in artificial intelligence in South Korea. Atopic dermatitis, a chronic inflammatory skin disease, is diagnosed via subjective evaluations without using objective diagnostic methods, thereby increasing the risk of misdiagnosis. It is also similar to psoriasis in appearance, further complicating its accurate diagnosis. Existing studies on skin diseases have used high-quality dermoscopic image datasets, but such high-quality images cannot be obtained in actual clinical settings. Moreover, existing systems must ensure accuracy and fast response times. To this end, an ensemble learning-based skin lesion detection system (ENSEL) was proposed herein. ENSEL enhanced diagnostic accuracy by integrating various deep learning models via an ensemble approach. Its performance was verified by conducting skin lesion detection experiments using images of skin lesions taken by actual users. Its accuracy and response time were measured using randomly sampled skin disease images. Results revealed that ENSEL achieved high recall in most images and less
Network meta-analysis (NMA) combines evidence from multiple trials comparing treatment options for the same condition. The method derives its name from a graphical representation of the data where nodes are treatments, and edges represent comparisons between treatments in trials. However, edges in this graph are limited to pairwise comparisons and fail to represent trials that compare more than two treatments. In this paper, we describe NMA as a bipartite graph where trials define a second type of node. Edges then correspond to the arms of trials, connecting each trial node to the treatment nodes it compares. We consider an NMA model parameterized in terms of the observations in each arm. By linking the hat matrix of this model to the bipartite framework, we reveal how evidence flows through the arms of trials. We then define a random walk on the bipartite graph and propose two conjectures that relate the movement of this walker to evidence flow. We illustrate our methods on a network of treatments for plaque psoriasis and verify our conjectures in simulations on randomly generated graphs. The bipartite framework provides new insights into the evidence structure of NMA and the role
Missing data are inevitable in clinical trials, and trials that produce categorical ordinal responses are not exempted from this. Typically, missing values in the data occur due to different missing mechanisms, such as missing completely at random, missing at random, and missing not at random. Under a specific missing data regime, when the conditional distribution of the missing data is dependent on the ordinal response variable itself along with other predictor variables, then the missing data mechanism is called nonignorable. In this article we propose an expectation maximization based algorithm for fitting a proportional odds regression model when the missing responses are nonignorable. We report results from an extensive simulation study to illustrate the methodology and its finite sample properties. We also apply the proposed method to a recently completed Phase III psoriasis study using an investigational compound. The corresponding SAS program is provided.